153 related articles for article (PubMed ID: 32095117)
21. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of histone-lysine N-methyltransferase EZH2 inhibits cell viability and enhances chemosensitivity in lung cancer cells.
Cao Z; Wu W; Wei H; Zhang W; Huang Y; Dong Z
Oncol Lett; 2021 Jan; 21(1):26. PubMed ID: 33240432
[TBL] [Abstract][Full Text] [Related]
23. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.
Takashina T; Kinoshita I; Kikuchi J; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Nishimura M; Dosaka-Akita H
Cancer Sci; 2016 Jul; 107(7):955-62. PubMed ID: 27116120
[TBL] [Abstract][Full Text] [Related]
24. Short hairpin RNA-mediated down-regulation of CENP-A attenuates the aggressive phenotype of lung adenocarcinoma cells.
Wu Q; Chen YF; Fu J; You QH; Wang SM; Huang X; Feng XJ; Zhang SH
Cell Oncol (Dordr); 2014 Dec; 37(6):399-407. PubMed ID: 25228009
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-133 inhibits the growth and metastasis of the human lung cancer cells by targeting epidermal growth factor receptor.
Liu S; Chen J; Zhang T; Chen H
J BUON; 2019; 24(3):929-935. PubMed ID: 31424644
[TBL] [Abstract][Full Text] [Related]
26. Dihydroartemisinin inhibits cell proliferation via AKT/GSK3β/cyclinD1 pathway and induces apoptosis in A549 lung cancer cells.
Liao K; Li J; Wang Z
Int J Clin Exp Pathol; 2014; 7(12):8684-91. PubMed ID: 25674233
[TBL] [Abstract][Full Text] [Related]
27. Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells.
Othman N; In LL; Harikrishna JA; Hasima N
PLoS One; 2013; 8(12):e81735. PubMed ID: 24339958
[TBL] [Abstract][Full Text] [Related]
28. Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo.
Xu C; Gui Q; Chen W; Wu L; Sun W; Zhang N; Xu Q; Wang J; Fu X
J Exp Clin Cancer Res; 2011 May; 30(1):63. PubMed ID: 21619686
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of Immature Colon Carcinoma Transcript 1 Inhibits Proliferation and Promotes Apoptosis of Non-Small Cell Lung Cancer Cells.
Wang Y; He J; Zhang S; Yang Q; Wang B; Liu Z; Wu X
Technol Cancer Res Treat; 2017 Oct; 16(5):559-569. PubMed ID: 27413166
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-30a-3p inhibits the progression of lung cancer via the PI3K/AKT by targeting DNA methyltransferase 3a.
Wei D; Yu G; Zhao Y
Onco Targets Ther; 2019; 12():7015-7024. PubMed ID: 31695416
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells.
Kikuchi J; Takashina T; Kinoshita I; Kikuchi E; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Marquez VE; Nishimura M; Dosaka-Akita H
Lung Cancer; 2012 Nov; 78(2):138-43. PubMed ID: 22925699
[TBL] [Abstract][Full Text] [Related]
32. MADD promotes the survival of human lung adenocarcinoma cells by inhibiting apoptosis.
Bi W; Wei Y; Wu J; Sun G; Guo Y; Zhang Q; Dong L
Oncol Rep; 2013 Apr; 29(4):1533-9. PubMed ID: 23443411
[TBL] [Abstract][Full Text] [Related]
33. Zebularine inhibits the growth of A549 lung cancer cells via cell cycle arrest and apoptosis.
You BR; Park WH
Mol Carcinog; 2014 Nov; 53(11):847-57. PubMed ID: 23661569
[TBL] [Abstract][Full Text] [Related]
34. Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma.
Zhou Y; Zheng X; Xu B; Deng H; Chen L; Jiang J
Aging (Albany NY); 2020 Nov; 12(24):25189-25206. PubMed ID: 33223508
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer.
Del Bufalo D; Desideri M; De Luca T; Di Martile M; Gabellini C; Monica V; Busso S; Eramo A; De Maria R; Milella M; Trisciuoglio D
Mol Cancer; 2014 Oct; 13():230. PubMed ID: 25301686
[TBL] [Abstract][Full Text] [Related]
36. Growth arrest and apoptosis via caspase activation of dioscoreanone in human non-small-cell lung cancer A549 cells.
Hansakul P; Aree K; Tanuchit S; Itharat A
BMC Complement Altern Med; 2014 Oct; 14():413. PubMed ID: 25342427
[TBL] [Abstract][Full Text] [Related]
37. Adiponectin down-regulates CREB and inhibits proliferation of A549 lung cancer cells.
Illiano M; Nigro E; Sapio L; Caiafa I; Spina A; Scudiero O; Bianco A; Esposito S; Mazzeo F; Pedone PV; Daniele A; Naviglio S
Pulm Pharmacol Ther; 2017 Aug; 45():114-120. PubMed ID: 28506662
[TBL] [Abstract][Full Text] [Related]
38. Isolinderalactone inhibits proliferation of A549 human non‑small cell lung cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas receptor and soluble Fas ligand-mediated apoptotic pathway.
Chang WA; Lin ES; Tsai MJ; Huang MS; Kuo PL
Mol Med Rep; 2014 May; 9(5):1653-9. PubMed ID: 24604009
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.
Singh T; Prasad R; Katiyar SK
Epigenetics; 2013 Jan; 8(1):54-65. PubMed ID: 23221619
[TBL] [Abstract][Full Text] [Related]
40. Small interfering RNA targeting S100A4 sensitizes non-small-cell lung cancer cells (A549) to radiation treatment.
Qi R; Qiao T; Zhuang X
Onco Targets Ther; 2016; 9():3753-62. PubMed ID: 27382312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
